[1]Shen M, Pan H, Chen Y, et al. A review of current progress in triplenegative breast cancer therapy[J]. Open Med (Wars), 2020, 15(1):1143-1149.
[2]Mediratta K, ElSahli S, D′Costa V, et al. Current progresses and challenges of immunotherapy in triplenegative breast cancer[J]. Cancers, 2020, 12(12):E3529.
[3]Qattan A. Novel miRNA targets and therapies in the triplenegative breast cancer microenvironment: an emerging hope for a challenging disease[J]. Int J Mol Sci, 2020, 21(23):8905.
[4]朱宇,胡格,凌锐,等. ACSS2上调参与食管鳞癌细胞缺氧诱导的放疗抵抗[J].江苏大学学报(医学版),2017,27(3):200-204.
[5]苏玉婷,凌锐,周月鹏,等. 敲低乙酰辅酶A合成酶短链家族成员2(ACSS2)抑制营养缺乏诱导的宫颈癌细胞迁移和侵袭及机制[J]. 细胞与分子免疫学杂志,2019, 35(10): 926-931.
[6]Zhang S, He J, Jia Z, et al. AcetylCoA synthetase 2 enhances tumorigenesis and is indicative of a poor prognosis for patients with renal cell carcinoma[J]. Urol Oncol, 2018, 36(5):243.e9-243.e20.
[7]蔡丽君,苏榕,李宁宁. 乙酰辅酶A合成酶2促进肿瘤转移作用的探讨[J]. 广州医科大学学报, 2018, 46(5):97-100.
[8]糜磊,武丹,陶清,等. 乙酰辅酶A合成酶2低表达人胃癌细胞株MGC803的顺铂敏感性观察[J]. 山东医药,2019,59(18):32-35.
[9]Yoshii Y, Furukawa T, Yoshii H, et al. Cytosolic acetylCoA synthetase affected tumor cell survival under hypoxia: the possible function in tumor acetylCoA/acetate metabolism[J]. Cancer Sci, 2009, 100(5): 821-827.
[10]Wang YH, Huang S, Zhu L, et al. Alternative transcription start site selection in ACSS2 controls its nuclear localization and promotes ribosome biosynthesis in hepatocellular carcinoma[J]. Biochem Biophys Res Commun, 2019, 514(3):632-638.
[11]Elmore S. Apoptosis: a review of programmed cell death[J]. Toxicol Pathol, 2007, 35(4):495-516.
[12]Song XF, Tian H, Zhang P, et al. Expression of cytcmediated mitochondrial apoptosisrelated proteins in rat renal proximal tubules during development[J]. Nephron, 2017, 135(1):77-86.
[13]Yao H, Zhang X, Zhang N, et al. Wikstromol from wikstroemia indica induces apoptosis and suppresses migration of MDAMB231 cells via inhibiting PI3K/Akt pathway[J]. J Nat Med, 2021, 75(1):178-185.
[14]Du C, Wang Y, Zhang Y, et al. LncRNA DLX6AS1 contributes to epithelialmesenchymal transition and cisplatin resistance in triplenegative breast cancer via modulating mir199b5p/paxillin axis[J]. Cell Transplant, 2020, 29:963689720929983.
[15]Lin Q, Ling YB, Chen JW, et al. Circular RNA circCDK13 suppresses cell proliferation, migration and invasion by modulating the JAK/STAT and PI3K/AKT pathways in liver cancer[J]. Int J Oncol, 2018, 53(1):246-256.
[16]Wang S, Lei Y, Cai Z, et al. Girdin regulates the proliferation and apoptosis of pancreatic cancer cells via the PI3K/Akt signalling pathway[J]. Oncol Rep, 2018, 40(2):599-608.
[17]Cao B, Liu C, Yang G. Downregulation of lncRNA ADAMTS9AS2 contributes to gastric cancer development via activation of PI3K/Akt pathway[J]. Biomed Pharmacother, 2018, 11(107):185-193.
[18]Yao H, Su S, Xia D, et al. Fbox and leucinerich repeat protein 5 promotes colon cancer progression by modulating PTEN/PI3K/AKT signaling pathway[J]. Biomed Pharmacother, 2018, 11(107):1712-1719.
[19]Niu L, Yang S, Zhao X, et al. Sericin inhibits MDAMB468 cell proliferation via the PI3K/Akt pathway in triplenegative breast cancer[J]. Mol Med Rep, 2021, 23(2):140.
[20]Ni Y, Yang Y, Ran J, et al. MiR15a5p inhibits metastasis and lipid metabolism by suppressing histone acetylation in lung cancer[J]. Free Radic Biol Med, 2020, 12(161): 150-162.
|